Papers

5

Total Citations

102

H-Index

5

About

Georgios Gemenetzis is a leading surgical oncologist whose research is reshaping the landscape of pancreatic surgery through the rigorous evaluation of robotic-assisted techniques. His work centers on comparing robotic and open approaches for complex pancreatic resections, including pancreatoduodenectomy and total pancreatectomy, with a particular focus on patients with pancreatic ductal adenocarcinoma (PDAC). Gemenetzis has made landmark contributions by demonstrating the feasibility and safety of robotic surgery even in high-stakes scenarios, such as those requiring vascular resection. His most cited work, the PORTAL trial protocol (44 citations), establishes a framework for a multicenter phase III randomized controlled trial to definitively assess non-inferiority. Further impact is seen in his propensity score-matched studies (21-22 citations), which provide critical evidence on surgical and oncological outcomes, including the ability to deliver adjuvant chemotherapy. By pioneering robotic enucleation for proximal pancreatic tumors and rigorously analyzing long-term oncological results, Gemenetzis is systematically building the evidence base needed to expand minimally invasive options for patients with pancreatic cancer, directly challenging traditional open surgery paradigms.

Research Focus

Key Achievements

5
H-Index
5
Papers
102
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial
44 citations · 2021
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: Glasgow Royal Infirmary, Edinburgh Royal Infirmary, Ninewells Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago